Patent · US Active

Galactoside inhibitors of galectins

US7638623B2 · kind B2 · utility

15Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 2006
Grant dateDec 29, 2009
Priority date
Expiry dateNov 17, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H15/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds and the use of said compounds as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal. Said galectin is preferably galectin-3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.